Literature DB >> 19651603

Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.

Josephine C Ferreon1, Maria A Martinez-Yamout, H Jane Dyson, Peter E Wright.   

Abstract

The adenovirus early region 1A (E1A) oncoprotein mediates cell transformation by deregulating host cellular processes and activating viral gene expression by recruitment of cellular proteins that include cyclic-AMP response element binding (CREB) binding protein (CBP)/p300 and the retinoblastoma protein (pRb). While E1A is capable of independent interaction with CBP/p300 or pRb, simultaneous binding of both proteins is required for maximal biological activity. To obtain insights into the mechanism by which E1A hijacks the cellular transcription machinery by competing with essential transcription factors for binding to CBP/p300, we have determined the structure of the complex between the transcriptional adaptor zinc finger-2 (TAZ2) domain of CBP and the conserved region-1 (CR1) domain of E1A. The E1A CR1 domain is unstructured in the free state and upon binding folds into a local helical structure mediated by an extensive network of intermolecular hydrophobic contacts. By NMR titrations, we show that E1A efficiently competes with the N-terminal transactivation domain of p53 for binding to TAZ2 and that pRb interacts with E1A at 2 independent sites located in CR1 and CR2. We show that pRb and the CBP TAZ2 domain can bind simultaneously to the CR1 site of E1A to form a ternary complex and propose a structural model for the pRb:E1A:CBP complex on the basis of published x-ray data for homologous binary complexes. These observations reveal the molecular basis by which E1A inhibits p53-mediated transcriptional activation and provide a rationale for the efficiency of cellular transformation by the adenoviral E1A oncoprotein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651603      PMCID: PMC2726373          DOI: 10.1073/pnas.0906770106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.

Authors:  R N De Guzman; H Y Liu; M Martinez-Yamout; H J Dyson; P E Wright
Journal:  J Mol Biol       Date:  2000-10-20       Impact factor: 5.469

2.  The Amber biomolecular simulation programs.

Authors:  David A Case; Thomas E Cheatham; Tom Darden; Holger Gohlke; Ray Luo; Kenneth M Merz; Alexey Onufriev; Carlos Simmerling; Bing Wang; Robert J Woods
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor.

Authors:  Xin Liu; Ronen Marmorstein
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

4.  Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.

Authors:  Josephine C Ferreon; Chul Won Lee; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-08       Impact factor: 11.205

5.  The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.

Authors:  M Green; N K Panesar; P M Loewenstein
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

6.  cAMP-independent activation of the adenovirus type 12 E2 promoter correlates with the recruitment of CREB-1/ATF-1, E1A(12S), and CBP to the E2-CRE.

Authors:  P Fax; K S Lipinski; H Esche; D Brockmann
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

7.  Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.

Authors:  Jonathan M Wojciak; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

8.  Adenovirus small e1a alters global patterns of histone modification.

Authors:  Gregory A Horwitz; Kangling Zhang; Matthew A McBrian; Michael Grunstein; Siavash K Kurdistani; Arnold J Berk
Journal:  Science       Date:  2008-08-22       Impact factor: 47.728

9.  Epigenetic reprogramming by adenovirus e1a.

Authors:  Roberto Ferrari; Matteo Pellegrini; Gregory A Horwitz; Wei Xie; Arnold J Berk; Siavash K Kurdistani
Journal:  Science       Date:  2008-08-22       Impact factor: 47.728

10.  Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP.

Authors:  Peter Pelka; Jailal N G Ablack; Joseph Torchia; Andrew S Turnell; Roger J A Grand; Joe S Mymryk
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more
  64 in total

1.  A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.

Authors:  Jagat C Borah; Shiraz Mujtaba; Ioannis Karakikes; Lei Zeng; Michaela Muller; Jigneshkumar Patel; Natasha Moshkina; Keita Morohashi; Weijia Zhang; Guillermo Gerona-Navarro; Roger J Hajjar; Ming-Ming Zhou
Journal:  Chem Biol       Date:  2011-04-22

2.  Quantitative analysis of multisite protein-ligand interactions by NMR: binding of intrinsically disordered p53 transactivation subdomains with the TAZ2 domain of CBP.

Authors:  Munehito Arai; Josephine C Ferreon; Peter E Wright
Journal:  J Am Chem Soc       Date:  2012-02-15       Impact factor: 15.419

3.  Adenovirus E1A oncogene induces rereplication of cellular DNA and alters DNA replication dynamics.

Authors:  Ghata Singhal; Elisabetta Leo; Saayi Krushna Gadham Setty; Yves Pommier; Bayar Thimmapaya
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

4.  Structural and functional characterization of the acidic region from the RIZ tumor suppressor.

Authors:  Yizhi Sun; Jessica M Stine; Daniel Z Atwater; Ayesha Sharmin; J B Alexander Ross; Klára Briknarová
Journal:  Biochemistry       Date:  2015-02-02       Impact factor: 3.162

5.  Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor.

Authors:  Gabriel Gonzalez; Camden R Bair; Daryl M Lamson; Hidemi Watanabe; Laura Panto; Michael J Carr; Adriana E Kajon
Journal:  Virology       Date:  2019-09-08       Impact factor: 3.616

6.  Structure of the Taz2 domain of p300: insights into ligand binding.

Authors:  Maria Miller; Zbigniew Dauter; Scott Cherry; Joseph E Tropea; Alexander Wlodawer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-11-17

7.  Expanding the proteome: disordered and alternatively folded proteins.

Authors:  H Jane Dyson
Journal:  Q Rev Biophys       Date:  2011-07-01       Impact factor: 5.318

8.  Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.

Authors:  Peter Haberz; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Protein Sci       Date:  2016-10-15       Impact factor: 6.725

9.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

10.  A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.

Authors:  Horng D Ou; Witek Kwiatkowski; Thomas J Deerinck; Andrew Noske; Katie Y Blain; Hannah S Land; Conrado Soria; Colin J Powers; Andrew P May; Xiaokun Shu; Roger Y Tsien; James A J Fitzpatrick; Jeff A Long; Mark H Ellisman; Senyon Choe; Clodagh C O'Shea
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.